Authors’ Response to “Comment on ‘SMPDL3B as a novel biomarker and therapeutic target in myalgic encephalomyelitis’”

Journal of Translational Medicine 2026 Open access

Read full text

Authors: Bita Rostami-Afshari, Wesam Elremaly, Anita Franco, Alain Moreau

DOI: 10.1186/s12967-025-07583-z

Cited by: 0

References: 8

Fields of Study & Subjects

Fibromyalgia and Chronic Fatigue Syndrome Research Multiple Sclerosis Research Studies Long-Term Effects of COVID-19

References 8